GlobeNewswire Inc | May 19, 2021 11:15AM EDT

May 19, 2021

NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) -- FMW Medias New to The Street business TV show announces that it began filming a 6-part series about Pharmagreen Biotech, Inc. (OTCPINKS: PHBI).

Jane King, the TV shows host, interviews Mr. Peter Wojcik, CEO of Pharmagreen Biotech, Inc., talk together, about the entities on-goings. Throughout the 6- part televised series, Mr. Wojcik and other Company team members discuss the operational fundamentals of the Company in becoming one of the largest producers of hemp starter plantlets to meet the rapidly increasing hemp market demand for high CBD products.

"My team and I are excited to work with the highly professionalexperts at New to TheStreet, while they begin to market our Company via their national media network inclusive of Fox News, Bloomberg,Fox Business Network,CNN, CNBC,Newsmax TV and othersyndicate media networks. Pharmagreen'sbusiness development strategy utilizes outside the box proprietarytechnologiesalong with latest IoT technologies that are integratedin our Biotech Complex design and engineering. Pharmagreen welcomes working with New to the Street and their extensive media network, as we share more news over the next fewmonths onPharmagreen's progress with business developments," stated Pharmagreen Biotech, Inc.s, CEO, Peter Wojcik.

Vincent Caruso, CEO FMW Media Corp. and the Creator / Producer of New to The Street TV states, Pharmagreen Biotech, Inc.s interviews with their team of professionals throughout the 6-part series provides our syndicated television audience an in-depth understanding of their profound and successful business model. Their extensive experiences and understandings of the ever growing hemp marketing of CBD products, and their proprietary starter plantlets will provide our audiences valuable knowledge. I am excited to have Pharmagreen Biotech, Inc. and their team on our syndicated TV series.

The first interview on New to The Street with Mr. Peter Wojcik, CEO, Pharmagreen Biotech, Inc.s and with TV host Jane King, can be seen this Sunday, May 23, 2021 at 10-11 AM ET, Newsmax TV. A subsequent broadcast of the interview can be viewed on the Fox Business Network on Monday, May 24, 2021 at 10:30 PT.

About Pharmagreen Biotech, Inc.:

Pharmagreen Biotech, Inc., is a publicly traded (OTC PINKS: PHBI) company. Pharmagreen is a Company focused on the CBD hemp industry for the production and supply of starter plantlets through a proprietary tissue culture process with the opportunity to become one of the largest players globally. Pharmagreens mission is to advance the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same plantlets to CBD hemp farmers and other flora while offering full spectrum DNA testing for plant identification, live genetics preservation using tissue cultures in low temperature storage for all plant species; extraction of botanical oils mainly CBD oil, and to deliver laboratory based services to the North American Cannabis and agriculture sectors. For further information on the company please visitwww.pharmagreen.ca.

About FMW Media:

FMW Media operates one of the longest-running U.S and International sponsored and Syndicated Nielsen Rated programming TV brands "New to the Street," and its blockchain show "Exploring The Block." Since 2009, these brands run biographical interview segment shows across major U.S. Television networks. The TV platforms reach over 540 million homes both in the US and international markets. FMW recently added Newsmax to its broadcasting platform with its first show broadcasted Sunday, December 27th. The NEWSMAX- New to The Street show is syndicated on Sundays at 10-11 AM ET, and broadcasted on Fox Business Network, Mondays and Tuesdays at 10:30 PM PT. FMW is also one of the nation's largest buyers of linear Television long and short form- https://www.newsmaxtv.com/Shows/New-to-the-Streetand https://www.newtothestreet.com/

Safe Harbor Statement:

This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. In particular, factors that could cause actual results to differ materially from those in forward looking statements include: our inability to obtain additional financing on acceptable terms; risk that our products and services will not gain widespread market acceptance; inability to compete with others who provide comparable products; the failure of our technology; the infringement of our technology with proprietary rights of third parties; inability to respond to consumer demands; inability to replace significant customers; seasonal nature of our business. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements. When used in this document, the words "believe," "expect," "anticipate," "estimate," "project," "plan," "should," "intend," "may," "will," "would," "potential," and similar expressions may be used to identify forward-looking statements.

The OTC Markets or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release that has been prepared by management.

New to The Street TV Contact;

NewtoTheStreet.comSupport@NewtoTheStreet.com

Pharmagreen Biotech, Inc. Contact: www.pharmagreen.ca Tel: (702) 803 9404 info@pharmagreen.ca

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fde4953d-a656-47c0-8754-30fa20799662